S Schwartz, R Sievers, P Strange, WH Lyness … - Diabetes care, 2003 - Am Diabetes Assoc RESULTS—At the end of study (week 24 of therapy), A1C and fasting plasma
glucose (FPG) values showed comparable decreases in the two treatment groups.
Only 31% (oral therapy) and 32% (insulin plus metformin) of subjects ... Cited by 9 - Related articles - BL Direct - All 6 versions
M Monami, C Lamanna, N Marchionni, E … - Diabetes research and clinical practice, 2008 - Elsevier Metformin is recommended as first-line treatment in type 2 diabetic patients.
Several agents can be used as add-on treatments in metformin monotherapy
failure. Most available clinical trials on the hypoglycemic efficacy of ... Cited by 12 - Related articles - All 26 versions
- ►diabetesjournals.org E Al-Ozairi, L Sibal, P Home - Diabetes care, 2007 - Am Diabetes Assoc A Diabetes Outcome Progression Trial (ADOPT) was conceived in the hope that the
seemingly inexorable decline in islet B-cell function described with metformin,
sulfonylureas, and insulin in the UK Prospective Diabetes Study (UKPDS) ... Cited by 3 - Related articles - BL Direct - All 5 versions
- Free from Publisher SE Kahn, B Zinman - Diabetes Care, 2007 - Am Diabetes Assoc The treatment options for type 2 diabetes were for many years limited to
sulfonylureas, metformin, and insulin. However, in the last decade or so, a
number of new oral and injectable agents have been introduced including the ... Cited by 4 - Related articles - All 4 versions
J Guevara-Aguirre, M Guevara, J Saavedra, M … - Diabetes/Metabolism Reviews - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 19 - Related articles - BL Direct - All 4 versions
BJ Goldstein - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc The long-term goals for the management of type 2 diabetes mellitus (T2DM) center
on the prevention of its chronic micro- and macrovascular complications, which
requires normalization of glycemia and control of cardiovascular risk ... Cited by 6 - Related articles - All 2 versions
E Fleury-Milfort - Journal of the American Academy of Nurse …, 2008 - ingentaconnect.com The incidence of type 2 diabetes is increasing at an alarming rate. More
aggressive treatment, based on the pathophysiology of the disease, is necessary
and should include greater attention to control both fasting and postmeal ... Related articles - All 2 versions
